Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Proc Natl Acad Sci U S A ; 107(32): 14093-8, 2010 Aug 10.
Artículo en Inglés | MEDLINE | ID: mdl-20660316

RESUMEN

The pharmacologic utility of lengthy peptides can be hindered by loss of bioactive structure and rapid proteolysis, which limits bioavailability. For example, enfuvirtide (Fuzeon, T20, DP178), a 36-amino acid peptide that inhibits human immunodeficiency virus type 1 (HIV-1) infection by effectively targeting the viral fusion apparatus, has been relegated to a salvage treatment option mostly due to poor in vivo stability and lack of oral bioavailability. To overcome the proteolytic shortcomings of long peptides as therapeutics, we examined the biophysical, biological, and pharmacologic impact of inserting all-hydrocarbon staples into an HIV-1 fusion inhibitor. We find that peptide double-stapling confers striking protease resistance that translates into markedly improved pharmacokinetic properties, including oral absorption. We determined that the hydrocarbon staples create a proteolytic shield by combining reinforcement of overall alpha-helical structure, which slows the kinetics of proteolysis, with complete blockade of peptide cleavage at constrained sites in the immediate vicinity of the staple. Importantly, double-stapling also optimizes the antiviral activity of HIV-1 fusion peptides and the antiproteolytic feature extends to other therapeutic peptide templates, such as the diabetes drug exenatide (Byetta). Thus, hydrocarbon double-stapling may unlock the therapeutic potential of natural bioactive polypeptides by transforming them into structurally fortified agents with enhanced bioavailability.


Asunto(s)
Fármacos Anti-VIH/química , Inhibidores de Fusión de VIH/química , Hidrocarburos/química , Péptidos/farmacocinética , Disponibilidad Biológica , Inhibidores de Fusión de VIH/farmacocinética , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/prevención & control , Humanos , Hidrocarburos/uso terapéutico , Péptidos/uso terapéutico , Relación Estructura-Actividad
2.
Phytother Res ; 25(10): 1537-46, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21394806

RESUMEN

Oldenlandia diffusa (OD) has been used as a natural drug for the treatment of cancer in Asia and specifically in Korea. However, the antiinflammatory mechanisms employed by OD have yet to be completely understood. This study attempted to determine the effects of OD and hentriacontane, one of the constituent compounds of OD, on lipopolysaccharide (LPS)-induced inflammatory responses in mouse peritoneal macrophages. The findings of this study showed that OD inhibited the production of tumor necrosis factor (TNF)-α, interleukin (IL)-6 and prostaglandin E(2) (PGE(2)). The OD inhibited the enhanced levels of cyclooxygenase (COX)-2 and inducible nitric oxide synthase (iNOS) induced by LPS. It was shown that the antiinflammatory effect of OD occurs via the regulation of the activation of nuclear factor (NF)-κB and caspase-1. Moreover, hentriacontane was shown to ameliorate the expression of inflammatory mediators (TNF-α, IL-6, PGE(2), COX-2 and iNOS) and the activation of NF-κB and caspase-1 in LPS-stimulated peritoneal macrophages. These results provide novel insights into the pharmacological actions of OD as a potential candidate for the development of new drugs for the treatment of inflammatory diseases.


Asunto(s)
Antiinflamatorios/farmacología , Caspasa 1/metabolismo , Hidrocarburos/farmacología , Mediadores de Inflamación/metabolismo , Macrófagos Peritoneales/efectos de los fármacos , Oldenlandia/química , Extractos Vegetales/farmacología , Animales , Antiinflamatorios/uso terapéutico , Inhibidores de la Ciclooxigenasa/farmacología , Inhibidores de la Ciclooxigenasa/uso terapéutico , Dinoprostona/metabolismo , Hidrocarburos/uso terapéutico , Inflamación/inducido químicamente , Inflamación/tratamiento farmacológico , Inflamación/metabolismo , Interleucina-6/metabolismo , Lipopolisacáridos , Macrófagos Peritoneales/metabolismo , Ratones , FN-kappa B/metabolismo , Óxido Nítrico Sintasa de Tipo II/metabolismo , Fitoterapia , Extractos Vegetales/uso terapéutico , Factor de Necrosis Tumoral alfa/metabolismo
3.
Med Parazitol (Mosk) ; (3): 28-31, 2011.
Artículo en Ruso | MEDLINE | ID: mdl-21932544

RESUMEN

The authors developed a technology for preparing a hydrocarbon extract from the medicinal raw material of Circassian walnut (Juglans regia), including its green fruits, green leaves, and fresh roots. To prepare the preparation, they obtained for the first time a new extragent called petroleum Russia that was found to contain more than hundred chemical compounds by chromatography mass spectrometry. The new agent was named irillen. Experiments on albino mice and albino rats established that the new agent was low toxic. The lethal doses of irillen were calculated: LD50 was 16377 +/- 457.5 mg/kg; LD16 = 12986.4 mg/kg; LD84 was 18976.6 mg/kg for albino mice; LD50 was 16998.0 +/- 535.4 mg/kg; LD16 = 12875.3 mg/ kg; LD84 = 18583.4 mg/kg for albino rats. The irillen prepared by the authors should be referred to as a low toxic and practically nontoxic agent (Toxicity Class IV and V). Irillen has a broad spectrum of antiparasitic activity. It is effective in treating toxocariasis in dogs, larval alveolar echinococcosis, ascaridiasis, and eimeriasis in chickens, and siphachiasis.


Asunto(s)
Ascarídidos/efectos de los fármacos , Coccidiosis/tratamiento farmacológico , Equinococosis Hepática/tratamiento farmacológico , Echinococcus/efectos de los fármacos , Eimeriida/efectos de los fármacos , Juglans/química , Extractos Vegetales , Toxocariasis/tratamiento farmacológico , Animales , Antiparasitarios/uso terapéutico , Ascarídidos/crecimiento & desarrollo , Pollos/parasitología , Coccidiosis/parasitología , Perros , Equinococosis Hepática/parasitología , Echinococcus/crecimiento & desarrollo , Eimeriida/crecimiento & desarrollo , Hidrocarburos/química , Hidrocarburos/farmacología , Hidrocarburos/uso terapéutico , Dosificación Letal Mediana , Ratones , Ratones Endogámicos/parasitología , Nueces/química , Extractos Vegetales/química , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Hojas de la Planta/química , Raíces de Plantas/química , Ratas , Ratas Endogámicas/parasitología , Federación de Rusia , Toxocariasis/parasitología
4.
Medicine (Baltimore) ; 99(12): e19519, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-32195954

RESUMEN

BACKGROUND: The purposes of this study were to examine the feasibility of using the MyotonPRO digital palpation device in measuring the passive stiffness of gastrocnemius muscle belly and Achilles tendon; to determine between-days test-retest reliability of MyotonPRO; and to evaluate the acute effect of paraffin therapy on stiffness measurements in healthy participants. METHODS: It is a randomized controlled trial. Twenty healthy participants (male, n = 10; female, n = 10; total, n = 20) were recruited to evaluate the passive stiffness of gastrocnemius muscle belly and Achilles tendon. Dominant and nondominant legs were randomly divided into an experimental side (20 cases) and a control side (20 cases). The experimental side received 20 minutes of paraffin therapy. RESULTS: The stiffness of muscle and tendon in the experimental side decreased significantly after paraffin therapy (P < .01), whereas no significant differences in stiffness measurements were found in the control side (P > .05). The passive stiffness of muscle and tendon was positively correlated with the ankle from 30° plantar flexion to10° dorsiflexion for dominant legs. Between-days test-retest reliability in stiffness measurements was high or very high (ICCs were above 0.737). CONCLUSION: Paraffin therapy induces a decrease in the passive stiffness of gastrocnemius muscle belly and Achilles tendon. Furthermore, the MyotonPRO can reliably determine stiffness measurements.


Asunto(s)
Tendón Calcáneo/efectos de los fármacos , Hidrocarburos/uso terapéutico , Tono Muscular/efectos de los fármacos , Músculo Esquelético/efectos de los fármacos , Parafina/uso terapéutico , Tendón Calcáneo/fisiopatología , Adolescente , Adulto , Articulación del Tobillo/fisiología , Femenino , Humanos , Masculino , Músculo Esquelético/fisiopatología , Modalidades de Fisioterapia/tendencias , Rango del Movimiento Articular/fisiología , Reproducibilidad de los Resultados , Adulto Joven
5.
Acta Med Hist Adriat ; 16(2): 283-292, 2018 10 29.
Artículo en Inglés | MEDLINE | ID: mdl-30488706

RESUMEN

AIM: Bitumen is a natural substance effusing from rocks' notches in some highland areas; it has been known as an effective remedy for treating some illnesses. Considering pain relieving properties of bitumen in traditional Persian medicine (TPM) sources, this study aims to review the viewpoints of TPM sages regarding bitumen in the context of traditional Persian medicine. It also provides applicable information for interested researchers to conduct well-designed clinical trials and evaluate therapeutic effects of bitumen claimed in TPM sources. MATERIAL AND METHOD: Various databases including Embase, SID, IRANDOC, IranMedex, Scopus and PubMed were searched with keywords "bitumen" and "Shilajit". Furthermore, main traditional Persian medicine sources including Avicenna's "Canon of medicine", "Continens Liber" by Razes, "The storehouse of medicaments" by Aghili, "Gift for the faithful" by Momen Tonekaboni and "Measure for medicine" written by Muhammad Akbar Shah Arzani were reviewed with Persian keywords "Moomiaii" and "Mumnaei" Results: According to TPM sources, bitumen was used by Iranian's physicians to treat a wide range of diseases. It was known especially as an effective remedy to improve gastrointestinal digestive problems. CONCLUSION: Bitumen is cited in traditional Persian medicine sources as an effective remedy for treatment of a wide range of diseases, especially GI disorders and bone pain. Recent studies showed the beneficial effects of bitumen in treatment of wound healing, however using it in medical practice for other health dilemma should be confirmed by conducting well-designed clinical studies in the future.


Asunto(s)
Hidrocarburos/historia , Medicina Tradicional/historia , Minerales/historia , Resinas de Plantas/historia , Historia Antigua , Historia Medieval , Humanos , Hidrocarburos/uso terapéutico , Irán , Minerales/uso terapéutico , Persia , Resinas de Plantas/uso terapéutico
6.
J Med Chem ; 49(1): 334-48, 2006 Jan 12.
Artículo en Inglés | MEDLINE | ID: mdl-16392818

RESUMEN

A series of long (11-15) hydrocarbon chain diols and diacids with various central functional groups and terminal gem-dimethyl or -methyl/aryl substituents was synthesized and evaluated in both in vivo and in vitro assays for its potential to favorably alter lipid disorders including metabolic syndrome. Compounds were assessed for their effects on the de novo incorporation of radiolabeled acetate into lipids in primary cultures of rat hepatocytes, as well as for their effects on lipid and glycemic variables in obese female Zucker fatty rats, Crl:(ZUC)-faBR. The most active compounds were hydroxyl-substituted symmetrical diacids and diols with a 13-atom chain and terminal gem-dimethyl substituents. Furthermore, biological activity was enhanced by central substitution with O, C=O, S, S=O compared to the methylene analogues and was diminished for compounds with central functional groups such as carbamate, ester, urea, acetylmethylene, and hydroxymethylene.


Asunto(s)
Alcoholes/uso terapéutico , Diabetes Mellitus Experimental/tratamiento farmacológico , Ácidos Dicarboxílicos/uso terapéutico , Hidrocarburos/uso terapéutico , Hiperlipidemias/tratamiento farmacológico , Hipolipemiantes/uso terapéutico , Administración Oral , Alcoholes/administración & dosificación , Alcoholes/síntesis química , Animales , Diabetes Mellitus Experimental/metabolismo , Ácidos Dicarboxílicos/administración & dosificación , Ácidos Dicarboxílicos/síntesis química , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Tolerancia a Medicamentos , Femenino , Hepatocitos/efectos de los fármacos , Hidrocarburos/administración & dosificación , Hidrocarburos/síntesis química , Hiperlipidemias/metabolismo , Hipolipemiantes/administración & dosificación , Hipolipemiantes/síntesis química , Técnicas In Vitro , Lípidos/antagonistas & inhibidores , Lípidos/biosíntesis , Estructura Molecular , Ratas , Ratas Zucker , Relación Estructura-Actividad , Factores de Tiempo
7.
Folia Med Cracov ; 31(4): 267-78, 1990.
Artículo en Polaco | MEDLINE | ID: mdl-2152095

RESUMEN

Occupational medicine is interested in effective prophylaxis of skin occupational diseases. Use of protective ointments and creams makes one of prophylaxis methods of professional dermatitis. The purpose of the investigation was to evaluate both the primarily irritant and the allergic action of the two creams devised by us for protection of skin exposed to aqueous solution of electrolytes. One of these creams was composed of hydrocarbons components, the other had in addition silicone oil and cetaceum. Protective properties of these creams in patients with allergic contact dermatitis were also examined. The experiments were carried out on 10 rabbits, 75 guinea pigs, and 491 patients mainly suffering from metal (Cr, Co, Ni) and formaldehyde allergy. It was found that investigated creams do not exert primarily irritant and sensitizing effects both in animals and humans. These creams demonstrate pronounced protective action in allergy due to water soluble allergens.


Asunto(s)
Dermatitis por Contacto/prevención & control , Dermatitis Profesional/prevención & control , Hidrocarburos/uso terapéutico , Aceites de Silicona/uso terapéutico , Adulto , Animales , Dermatitis por Contacto/etiología , Dermatitis Profesional/inducido químicamente , Formaldehído/efectos adversos , Cobayas , Humanos , Metales/efectos adversos , Persona de Mediana Edad , Conejos
9.
Curr Med Chem ; 21(5): 519-52, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24083611

RESUMEN

Since Human CYP1 enzymes catalyze the metabolic activation of procarcinogens and deactivation of certain anticancer drugs, the inhibition of these enzymes has been considered as an effective approach for chemoprevention and treatment of CYP1-mediated drug resistance. Recent knowledge relating to the enhanced expression of CYP1B1 in tumors also provided certain advantages in cancer therapy by the activation of prodrugs only in tumor cells. This review concentrates on the characterized CYP1 inhibitors and CYP1-activatied anticancer prodrugs. The mechanism for enzyme inhibition and activation of prodrugs, the cancer preventive/therapeutic potential of these chemicals and their related SARs are highlighted. According to their structural features, CYP1 inhibitors are divided into the following categories: flavonoids, trans-stilbenes, coumarins, terpenoids, alkaloids, quinones, isothiocyanates and synthetic aromatics. In the same way, CYP1-activatied prodrugs are categorized into four groups: benzothiazoles, flavonoids, stilbenes and alkylating agents. Almost all of these inhibitors and prodrugs are planar molecules with one aromatic ring and some have similarity with identified CYP1 substrates. CYP1 inhibitors could effectively block the procarcinogen-induced tumor initiation in animal models and benefit us with chemoprevention. The advent of Phortress and aminoflavone as clinical candidates shows promising perspectives in developing CYP1-mediated prodrugs as chemotherapeutic drugs that are specifically activated in tumors. All of these preclinical and clinical studies indicate that inhibitors and prodrugs target CYP1 are promising anticancer strategies.


Asunto(s)
Antineoplásicos/uso terapéutico , Hidrocarburo de Aril Hidroxilasas/antagonistas & inhibidores , Inhibidores Enzimáticos/uso terapéutico , Neoplasias/tratamiento farmacológico , Profármacos/uso terapéutico , Antineoplásicos/química , Antineoplásicos/farmacología , Hidrocarburo de Aril Hidroxilasas/metabolismo , Supervivencia Celular/efectos de los fármacos , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Compuestos Heterocíclicos/química , Compuestos Heterocíclicos/farmacología , Compuestos Heterocíclicos/uso terapéutico , Humanos , Hidrocarburos/química , Hidrocarburos/farmacología , Hidrocarburos/uso terapéutico , Simulación del Acoplamiento Molecular , Neoplasias/prevención & control , Profármacos/química , Profármacos/farmacología
13.
Planta Med ; 72(8): 703-7, 2006 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-16732521

RESUMEN

The aim of this study was to investigate the behavioral effects of palmitone in the anti-anxiety response in experimental models in mice. In the elevated plus-maze test, palmitone (0.3, 1, 3, 10 and 30 mg/kg, I. P.) lengthened, from 50 % to 199 %, the time spent in the open arm region of the maze at all doses tested, as compared to the vehicle group ( P < 0.001). In relation to the rearing activity in the exploratory cylinder, palmitone significantly modified ( P < 0.05), in a dose-dependent manner, this activity by decreasing the number of rearings with an effective dose value (ED (50)) and 95 % confidence limits (CL (50)) of 0.79 (0.23 - 2.68) mg/kg. In addition, in the hole-board test, nose-poking was also significantly decreased ( P < 0.01) in a dose-dependent fashion [ED (50) (CL (50)) = 9.07 (4.51 - 18.26) mg/kg]. Moreover, palmitone at any dose caused no change in motor activity nor disruption in traction performance. In contrast, diazepam, used as reference drug, produced an anxiolytic effect with a significant and dose-dependent decrease in motor coordination accompanied by disruption of the traction performance. Behavioral studies suggest an anti-anxiety effect produced by palmitone, but its neuropharmacological profile differs from that observed for benzodiazepines such as diazepam.


Asunto(s)
Annona , Ansiolíticos/farmacología , Hidrocarburos/farmacología , Cetonas/farmacología , Aprendizaje por Laberinto/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Fitoterapia , Animales , Ansiolíticos/administración & dosificación , Ansiolíticos/uso terapéutico , Relación Dosis-Respuesta a Droga , Hidrocarburos/administración & dosificación , Hidrocarburos/uso terapéutico , Inyecciones Intraperitoneales , Cetonas/administración & dosificación , Cetonas/uso terapéutico , Masculino , Ratones , Extractos Vegetales/administración & dosificación , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico
14.
Epilepsia ; 47(11): 1810-7, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17116019

RESUMEN

PURPOSE: To evaluate hypnotic and anticonvulsant activities of Annona diversifolia Saff. and palmitone by using behavior and electroencephalographic (EEG) analysis in an experimental model of focal seizures in rats. METHODS: For hypnotic assessment, EEG analysis of polysomnographic slow-wave sleep (SWS) and rapid eye movement (REM) sleep for a 1 h period were performed after vehicle, A. diversifolia extract or palmitone, administration. For anticonvulsant effect, 60 minutes after treatments, EEG and behavior were analyzed during penicillin-induced seizures. Latency to the onset of the first paroxystic spike, first seizure and frequency, as well as seizure severity using Racine's scale, were determined. RESULTS: Palmitone, but not A. diversifolia extract, produced a delay in the latency to the SWS phase. In addition, both palmitone and extract decreased SWS duration and accumulated REM sleep phase. With regard to the seizures, both the extract and palmitone increased the latency to the onset of spikes and seizures, but also decreased the duration of penicillin-induced seizures. This reduction in the EEG recordings was associated with an attenuation in the severity of behavioral seizures. CONCLUSIONS: A. diversifolia and palmitone did not produce a sedative-hypnotic effect although both of them were effective in reducing the severity of behavioral and EEG seizures induced by penicillin in rats, suggesting that the diminution in the paroxystic activity by A. diversifolia is likely produced by palmitone through GABAergic neurotransmission. This study justifies and reinforces the traditional use of this plant in epilepsy.


Asunto(s)
Annona/química , Anticonvulsivantes/uso terapéutico , Conducta Animal/efectos de los fármacos , Electroencefalografía/efectos de los fármacos , Hidrocarburos/uso terapéutico , Cetonas/uso terapéutico , Preparaciones de Plantas/uso terapéutico , Convulsiones/inducido químicamente , Convulsiones/prevención & control , Animales , Anticonvulsivantes/farmacología , Modelos Animales de Enfermedad , Evaluación de Medicamentos , Electroencefalografía/estadística & datos numéricos , Hidrocarburos/farmacología , Cetonas/farmacología , Masculino , Penicilinas , Preparaciones de Plantas/farmacología , Polisomnografía/efectos de los fármacos , Ratas , Ratas Wistar , Convulsiones/tratamiento farmacológico , Sueño/efectos de los fármacos , Sueño REM/efectos de los fármacos
15.
Med Sci Monit ; 11(8): PI53-63, 2005 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-16049391

RESUMEN

BACKGROUND: The tolerability and the anti-inflammatory and immunosuppressive properties of a novel designed non-steroidal anti-inflammatory drug, M2000 (beta-D-mannuronic acid), were investigated in various experimental models. MATERIAL/METHODS: The anti-inflammatory and immunosuppressive properties of M2000 were tested in experimental models of rheumatoid arthritis (AIA) and multiple sclerosis (EAE). Its therapeutic potency on kidney diseases was studied using experimental models of nephrosis and immune complex glomerulonephritis (ICG). Biocompatibility and pharmacotoxicology assessment of M2000 was carried out using a fibrosarcoma cell line, zymography, and serum and urine determinants. RESULTS: Data showed that oral and/or i.p. administration of M2000 significantly reduces paw edema and histopathological parameters in arthritic rats. The immunosuppressive property of M2000 could significantly diminish clinical signs and histological erosions in the EAE model. Lymph node cell proliferation assay in EAE confirmed the immunosuppressive efficacy of the tested drug. Our findings in ICG and experimental nephrosis showed that M2000 enables a significant decrease in proteinuria, BUN, serum creatinine and cholesterol, as well as glomerular lesion in M2000-treated rats. Moreover, this drug inhibited MMP-2 activity. The pharmacotoxicology study showed that M2000 is the safest anti-inflammatory and immunosuppressive drug in comparison with dexamethasone and conventional NSAIDs tested. Additionally, M2000 had no ulcerogenic effect on the rat stomach. CONCLUSIONS: M2000 is the first novel designed NSAID with the lowest molecular weight, no gastro-nephrotoxicity, and therapeutic effects in glomerulonephritis and nephrosis and could be strongly recommended on an extensive scale as the safest drug for decreasing anti-inflammatory reactions.


Asunto(s)
Artritis Reumatoide/tratamiento farmacológico , Glomerulonefritis/tratamiento farmacológico , Hidrocarburos/farmacología , Hidrocarburos/uso terapéutico , Esclerosis Múltiple/tratamiento farmacológico , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Antiinflamatorios no Esteroideos/efectos adversos , Antiinflamatorios no Esteroideos/farmacología , Antiinflamatorios no Esteroideos/uso terapéutico , Anticuerpos/inmunología , Artritis Experimental/tratamiento farmacológico , Artritis Experimental/patología , Artritis Reumatoide/patología , Bovinos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Femenino , Glomerulonefritis/sangre , Glomerulonefritis/patología , Glomerulonefritis/orina , Miembro Posterior/efectos de los fármacos , Miembro Posterior/patología , Hidrocarburos/administración & dosificación , Hidrocarburos/efectos adversos , Terapia de Inmunosupresión , Interleucina-6/biosíntesis , Interleucina-6/metabolismo , Lípidos/sangre , Masculino , Metaloproteinasa 2 de la Matriz/metabolismo , Ratones , Esclerosis Múltiple/inducido químicamente , Esclerosis Múltiple/patología , Neuronas/efectos de los fármacos , Neuronas/patología , Ratas , Ratas Endogámicas Lew , Albúmina Sérica Bovina/inmunología
16.
Int J Dermatol ; 41(12): 877-80, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12492975

RESUMEN

BACKGROUND: Many methods have been employed, with variable success, in the treatment of cutaneous myiasis caused by Chrysomya species. AIMS: Experiment 1: to assess the larvicidal effect of mineral turpentine (MT) and the main ingredient of MT, low aromatic white spirits (LAWS), on Chrysomya megacephala larvae in vitro. Experiment 2: to assess the larvicidal effects of aqueous extracts of winged senna (Cassia alata), and aqueous extracts, ethanolic extracts and essential oil of betel leaf (Piper betle). METHODS: In experiment 1, two samples of LAWS were obtained from two industrialists (samples 1 and 2). Adult flies of C. megacephala were bred in the insectory of the Department of Parasitology, Faculty of Medicine, University of Colombo. Petri dishes were prepared with pads of cotton wool. These cotton pads were soaked separately in MT, LAWS samples 1 and 2, and normal saline as a control. Ten larvae were placed in each Petri dish. The activity of the larvae was observed and recorded half-hourly. MT and the two samples of LAWS were analyzed by chromatography. In experiment 2, volatile essential oil of betel was prepared using a standard steam distillation process. An ethanolic extract of betel was obtained after boiling the crushed leaf with water, and mixing the stock with ethanol. Betel oil dilutions of 1-4% were prepared using 1% Tween 80 (v/v aq) as a solvent, with 0.05 g/100 mL sodium lauryl sulphate (as stabilizer) and 0.01 g/100 mL methyl paraben (as a preservative). Cotton wool swabs soaked in 1, 2, 3 and 4% essential oil of betel in 1% Tween 80 (v/v aq) prepared as above, 1, 2, 3 and 4% ethanolic extract of betel, 50 and 25% aqueous extract of C. alata, and 50 and 25% aqueous extract of betel were placed in separate Petri dishes. Ten larvae were placed in each Petri dish. 1% Tween 80 solvent with the stabilizer and the preservative, but without betel essential oil, was used as a negative control and MT was used as a positive control. Larval motility was assessed as before. RESULTS: MT and the two LAWS samples killed the larvae in vitro within 4 h. Chromatography showed more unidentified constituents in MT than in pure LAWS, indicating additional substances in MT. The 4 and 3% preparations of the essential oil of betel were effective in killing 100% of the larvae of Chrysomya within 3 h 30 min. The 2% extract of betel essential oil killed 96.7% of larvae in 4 h. Ethanolic and aqueous extracts of betel, the aqueous extract of C. alata, normal saline and the Tween 80 solvent were not larvicidal. CONCLUSIONS: MT and LAWS, the main ingredient of MT, were effective in killing Chrysomya larvae. Essential oil obtained from betel leaves also showed a dose-dependent larvicidal effect on Chrysomya larvae. This natural product may be effective in the treatment of wound myiasis.


Asunto(s)
Cassia , Dípteros/efectos de los fármacos , Emolientes/farmacología , Hidrocarburos/farmacología , Irritantes/farmacología , Larva/efectos de los fármacos , Aceite Mineral/farmacología , Miasis/tratamiento farmacológico , Aceites Volátiles/farmacología , Fitoterapia , Piper betle , Extractos Vegetales/farmacología , Trementina/farmacología , Animales , Emolientes/uso terapéutico , Humanos , Hidrocarburos/uso terapéutico , Irritantes/uso terapéutico , Aceite Mineral/uso terapéutico , Aceites Volátiles/uso terapéutico , Extractos Vegetales/uso terapéutico , Factores de Tiempo , Trementina/uso terapéutico
17.
Immunopharmacol Immunotoxicol ; 26(4): 611-9, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15658609

RESUMEN

The therapeutic effect of M-2000 (C6H10O7) molecule was tested in Adriamycin-induced nephropathy. To induce experimental nephrosis, Adriamycin was given once by a single intravenous injection (7.5 mg/kg) through the tail vein. Six days after injection of Adriamycin, therapeutic protocol was developed by intraperitoneally (i.p) administration of 30 mg/kg M-2000 solution. Total of i.p. injections were 14, in which five injections were made every day and nine injections were carried out at regular 48-h intervals. Therapeutic protocol was terminated on day 28 and animals were killed on day 43. The treated patient rats showed a significant reduction in proteinuria, BUN, serum creatinine and serum cholesterol, as well as, administration of M-2000 could significantly diminish the serum level of interleukin-6 (IL-6) in treated animals compared to non-treated controls. Moreover, treatment with M-2000 significantly reduced number of glomerular leukocytes, Hypercellularity and hydropic change in capillary network within the renal cortex and decreased tubular casts. These data suggest that M-2000 therapy can ameliorate proteinuria, and suppress the progression of glomerular lesions in experimental model of nephrosis.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Hidrocarburos/uso terapéutico , Síndrome Nefrótico/tratamiento farmacológico , Proteinuria/tratamiento farmacológico , Animales , Antiinflamatorios no Esteroideos/administración & dosificación , Nitrógeno de la Urea Sanguínea , Creatinina/sangre , Modelos Animales de Enfermedad , Femenino , Hidrocarburos/administración & dosificación , Inyecciones Intraperitoneales , Interleucina-6/sangre , Interleucina-6/inmunología , Riñón/efectos de los fármacos , Riñón/patología , Pruebas de Función Renal , Lípidos/sangre , Síndrome Nefrótico/inmunología , Síndrome Nefrótico/patología , Proteinuria/inmunología , Proteinuria/patología , Ratas , Ratas Sprague-Dawley
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA